Articles with public access mandates - Leonard KrilovLearn more
Available somewhere: 7
Current state of respiratory syncytial virus disease and management
A Chatterjee, K Mavunda, LR Krilov
Infectious diseases and therapy 10 (Suppl 1), 5-16, 2021
Mandates: US National Institutes of Health
A framework for evaluation of the higher-risk infant after a brief resolved unexplained event
JL Merritt, RA Quinonez, JL Bonkowsky, WH Franklin, DA Gremse, ...
Pediatrics 144 (2), 2019
Mandates: US National Institutes of Health
Recent trends in RSV immunoprophylaxis: clinical implications for the infant
S Acero-Bedoya, PS Wozniak, PJ Sánchez, O Ramilo, A Mejias
American journal of perinatology 36 (S 02), S63-S67, 2019
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health
Prioritising respiratory syncytial virus prevention in low-income and middle-income countries
X Carbonell-Estrany, EAF Simões, LJ Bont, BA Paes, A Ayuk, A Gentile, ...
The Lancet Global Health 11 (5), e655-e657, 2023
Mandates: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Impact of the 2014 American Academy of Pediatrics policy on RSV hospitalization in preterm infants in the United States
M Goldstein, J Fergie, LR Krilov
Infectious Diseases and Therapy 10 (Suppl 1), 17-26, 2021
Mandates: US National Institutes of Health
Severity and cost of RSV hospitalization among US preterm infants following the 2014 American Academy of Pediatrics policy change
LR Krilov, ML Forbes, M Goldstein, R Wadhawan, DL Stewart
Infectious Diseases and Therapy 10, 27-34, 2021
Mandates: US National Institutes of Health
RSV Disease: Current Management and the Future of Treatment and Prevention
LR Krilov, JB Domachowske, EJ Anderson
Infectious Diseases and Therapy 10, 1-3, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program